These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


767 related items for PubMed ID: 10741713

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
    Srivastava P, Russo J, Mgbonyebi OP, Russo IH.
    Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
    [Abstract] [Full Text] [Related]

  • 45. Monensin inhibits the growth of renal cell carcinoma cells via cell cycle arrest or apoptosis.
    Park WH, Jung CW, Park JO, Kim K, Kim WS, Im YH, Lee MH, Kang WK, Park K.
    Int J Oncol; 2003 Apr; 22(4):855-60. PubMed ID: 12632079
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells.
    Delmas D, Passilly-Degrace P, Jannin B, Cherkaoui Malki M, Latruffe N.
    Int J Mol Med; 2002 Aug; 10(2):193-9. PubMed ID: 12119558
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase.
    Kim YB, Lee KH, Sugita K, Yoshida M, Horinouchi S.
    Oncogene; 1999 Apr 15; 18(15):2461-70. PubMed ID: 10229197
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1.
    Kominsky S, Johnson HM, Bryan G, Tanabe T, Hobeika AC, Subramaniam PS, Torres B.
    Oncogene; 1998 Dec 10; 17(23):2973-9. PubMed ID: 9881699
    [Abstract] [Full Text] [Related]

  • 55. IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells.
    Hobeika AC, Subramaniam PS, Johnson HM.
    Oncogene; 1997 Mar 13; 14(10):1165-70. PubMed ID: 9121765
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
    Patel V, Senderowicz AM, Pinto D, Igishi T, Raffeld M, Quintanilla-Martinez L, Ensley JF, Sausville EA, Gutkind JS.
    J Clin Invest; 1998 Nov 01; 102(9):1674-81. PubMed ID: 9802881
    [Abstract] [Full Text] [Related]

  • 58. Both low and high concentrations of staurosporine induce G1 arrest through down-regulation of cyclin E and cdk2 expression.
    Zong ZP, Fujikawa-Yamamoto K, Li AL, Yamaguchi N, Chang YG, Murakami M, Odashima S, Ishikawa Y.
    Cell Struct Funct; 1999 Dec 01; 24(6):457-63. PubMed ID: 10698260
    [Abstract] [Full Text] [Related]

  • 59. Calcitonin receptor-mediated growth suppression of HEK-293 cells is accompanied by induction of p21WAF1/CIP1 and G2/M arrest.
    Evdokiou A, Raggatt LJ, Atkins GJ, Findlay DM.
    Mol Endocrinol; 1999 Oct 01; 13(10):1738-50. PubMed ID: 10517675
    [Abstract] [Full Text] [Related]

  • 60. Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase activity via up-regulating p21Cip/WAF1 and down-regulating cyclin E in SK-HEP-1 cells.
    Lee KY, Lee YH, Kim SI, Park JH, Lee SK.
    Anticancer Res; 1997 Oct 01; 17(2A):1067-72. PubMed ID: 9137450
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 39.